Prime Medicine (PRME) Change in Acquisitions & Divestments (2021 - 2026)

Prime Medicine has reported Change in Acquisitions & Divestments for 6 years, with the latest figure at $50.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 1596.27% year-over-year to $50.9 million; the trailing twelve-month figure through Mar 2026 stood at $143.7 million (up 6.66% YoY), and the FY2025 full-year result was $95.8 million, down 53.09% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $50.9 million, up from $39.1 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $72.5 million in Q1 2024, with the low at $3.0 million in Q1 2025.
• Historically, Change in Acquisitions & Divestments has averaged $33.9 million across 5 years, with a median of $32.9 million in 2024.
• Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments tumbled 95.86% — and 2026, when it jumped 1596.27%.
• Prime Medicine's Change in Acquisitions & Divestments stood at $25.0 million in 2022, then surged by 90.14% to $47.5 million in 2023, then tumbled by 30.79% to $32.9 million in 2024, then gained by 18.84% to $39.1 million in 2025, then surged by 30.15% to $50.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $50.9 million (Q1 2026), $39.1 million (Q4 2025), and $42.4 million (Q3 2025), per Business Quant data.